These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
707 related articles for article (PubMed ID: 31173761)
1. Considerations for the Design of Antibody-Based Therapeutics. Goulet DR; Atkins WM J Pharm Sci; 2020 Jan; 109(1):74-103. PubMed ID: 31173761 [TBL] [Abstract][Full Text] [Related]
2. Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates. Acchione M; Kwon H; Jochheim CM; Atkins WM MAbs; 2012; 4(3):362-72. PubMed ID: 22531451 [TBL] [Abstract][Full Text] [Related]
3. Design and characterization of novel dual Fc antibody with enhanced avidity for Fc receptors. Goulet DR; Zwolak A; Williams JA; Chiu ML; Atkins WM Proteins; 2020 May; 88(5):689-697. PubMed ID: 31702857 [TBL] [Abstract][Full Text] [Related]
4. Current strategies in antibody engineering: Fc engineering and pH-dependent antigen binding, bispecific antibodies and antibody drug conjugates. Vincent KJ; Zurini M Biotechnol J; 2012 Dec; 7(12):1444-50. PubMed ID: 23125076 [TBL] [Abstract][Full Text] [Related]
14. Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Vaccaro C; Zhou J; Ober RJ; Ward ES Nat Biotechnol; 2005 Oct; 23(10):1283-8. PubMed ID: 16186811 [TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated complement activation in pathology and protection. Goldberg BS; Ackerman ME Immunol Cell Biol; 2020 Apr; 98(4):305-317. PubMed ID: 32142167 [TBL] [Abstract][Full Text] [Related]
16. Highly Potent, Anthracycline-based Antibody-Drug Conjugates Generated by Enzymatic, Site-specific Conjugation. Stefan N; Gébleux R; Waldmeier L; Hell T; Escher M; Wolter FI; Grawunder U; Beerli RR Mol Cancer Ther; 2017 May; 16(5):879-892. PubMed ID: 28258164 [TBL] [Abstract][Full Text] [Related]
18. Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA. Parren PW; Burton DR; Bradbury A; Huston JS; Carter PJ; Veldman T; Chester KA; Larrick JW; Alfenito MR; Scott JK; Weiner LM; Adams GP; Reichert JM MAbs; 2015; 7(6):981-8. PubMed ID: 26421752 [TBL] [Abstract][Full Text] [Related]
19. Antibody-Drug Conjugate-Based Therapeutics: State of the Science. Birrer MJ; Moore KN; Betella I; Bates RC J Natl Cancer Inst; 2019 Jun; 111(6):538-549. PubMed ID: 30859213 [TBL] [Abstract][Full Text] [Related]
20. The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates. Frigerio M; Kyle AF Curr Top Med Chem; 2017; 17(32):3393-3424. PubMed ID: 29357801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]